Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome

Science. 1990 Dec 21;250(4988):1707-8. doi: 10.1126/science.2270484.

Abstract

Epidemiologic studies strongly associate eosinophilia-myalgia syndrome (EMS) with ingestion of tryptophan containing a contaminant ("peak E"). Prior reports have suggested that peak E is the di-tryptophan N alpha-animal of acetaldehyde. Spectral and chemical studies now demonstrate that peak E is 1,1'-ethylidenebis[tryptophan]. This novel amino acid may be the etiological agent responsible for EMS, or it may be a marker of a still unidentified causal agent.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chromatography, High Pressure Liquid
  • Eosinophilia / chemically induced*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Muscles*
  • Pain / chemically induced*
  • Spectrometry, Mass, Fast Atom Bombardment
  • Syndrome
  • Tryptophan / analogs & derivatives*
  • Tryptophan / isolation & purification
  • Tryptophan / toxicity*

Substances

  • 1,1'-ethylidene bis(tryptophan)
  • Tryptophan